Neurocrine Biosciences CEO Kevin Gorman's 2018 pay rises 14% to $8.6M
Neurocrine Biosciences reports 2018 executive compensation
By ExecPay News
Published: April 9, 2020
Neurocrine Biosciences reported fiscal year 2018 executive compensation information on April 9, 2020.
In 2018, six executives at Neurocrine Biosciences received on average a compensation package of $5.1M, a 31% increase compared to previous year.
Average pay of disclosed executives at Neurocrine Biosciences
Kevin C. Gorman, Chief Executive Officer, received $8.6M in total, which increased by 14% compared to 2017. 52% of Gorman's compensation, or $4.5M, was in option awards. Gorman also received $425K in bonus, $675K in salary, $3M in stock awards, as well as $47K in other compensation.
For fiscal year 2018, the median employee pay was $259,000 at Neurocrine Biosciences. Therefore, the ratio of Kevin C. Gorman's pay to the median employee pay was 33 to one.
Eiry W. Roberts, Chief Medical Officer, received a compensation package of $8.3M. 49% of the compensation package, or $4.1M, was in stock awards.
Kyle W. Gano, Chief Business Development Officer, earned $4.6M in 2018, a 94% increase compared to previous year.
Eric Benevich, Chief Commercial Officer, received $3.7M in 2018, which increases by 23% compared to 2017.
Haig P. Bozigian, Chief Development Officer, earned $3M in 2018, a 1% increase compared to previous year.
Matthew C. Abernethy, Chief Financial Officer, received $2.7M in 2018, which decreases by 29% compared to 2017.
Related executives
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
Matthew Abernethy
Neurocrine Biosciences
Chief Financial Officer
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
Kyle Gano
Neurocrine Biosciences
Chief Development and Strategy Officer
Eiry Roberts
Neurocrine Biosciences
Chief Medical Officer
You may also like
Source: SEC filing on April 9, 2020.